Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery Equipment, Technologies and Companies, 2006-2011

Published by: Fuji-Keizai USA, Inc.

Published: Jan. 12, 2007 - 155 Pages


Table of Contents


1 What Cell Analysis is and What We Are Aiming for With This Research Project

1.1 Our Definition of the Cell Analysis Market

1.2 The Aim of This Research Report




2. Overview -- Current Market Status and R&D Status in Biotech and Pharma (Bio-Pharma) for Cell Analysis

2.1 Cell Based Screening & Analysis Helps Pharma Productivity

2.1.1 Drug Making Productivity

2.1.2 Increasing Use of Cell Based Screening and Analysis Platforms

2.2 Cell-Based Analysis Applications in Bio-Pharma Drug Discovery & Development

2.2.1 Traditional Pharma Drug Discovery Paradigm & Compound Screening

2.2.2 Drug Targets and Main Drug Target Classes

2.2.3 Cell Assay Development - Bio-pharmas Make Their Own Assays

2.2.4 High Throughput Screening (HTS) & High Content Screening (HCS)

2.2.5 Toxicology Testing (Safety Screening)

2.3 Current Equipment & Tools and R&D for Cell Analysis

2.4 Current Technologies and Related R&D for Cell Based Screening-Analysis

2.5 Current Reagents & Assays and Related R&D for Cell Based Screening-Analysis

2.6 Main Competitors by Large, Medium and Start-up (Emerging Companies)




3. Trends and Directions of Cell Based Screening and Analysis Equipment and Technologies

3.1 Trends: Cell Screening Equipment

3.1.1 Plate Imaging Equipment for Cell based HTS

3.1.2 Imaging Cytometry Equipment for HCS/ HCA

3.1.3 Emerging Developments In Cell Based Screening

3.2 Trends: Cell Screening Technologies

3.2.1 Labeling Reagents and No-Wash Assays

3.2.2 Cells as Reagents

3.2.3 Stem Cells Used as a Drug Discovery Tool




4 Alliances & IP

4.1 Summary and Review of Major M&As, Alliances, or Deals

4.1.1 M&A and Alliances at a Glance

4.1.2 Leading M&A Acquirers

4.1.3 Data Tables for M&As and Alliances Involving Cell-Based Analysis

4.2 Summary of Key Patent IP Involving Cell-Based Analysis




5 Market Size and Forecast 2006 to 2011

5.1 The Total Worldwide Cell-Based Screening-Analysis Market Size

5.2 Market Segments by Product Type and Revenues

5.2.1 Major Market Segments by Main Product Areas

5.2.2 Comparison of Major Market Segments by Market Shares, 2007& 2011

5.2.3 Equipment Segment by Product Type

5.2.4 'Consumables' Segment by Product Type

5.2.5 Content Segment by Product Type

5.2.6 Services Segment by Product Type

5.2.7 'Others' Segment by Product Type

5.3 Market Segments By Major Worldwide Regions

5.3.1 Region Segments

5.3.2 Comparison of Region Segments by Market Shares, 2007 & 2011

5.4 Outlook for Leading Commercial Vendors Market Share Rank




6 Activities of Cell Based Screening-Analysis Companies

6.1 Multiplatform Cell Screening/Analysis Systems

6.1.1 to 6.1.7 Total 7 companies

6.2 Flow Cytometry Screening Systems

6.2.1 to 6.2.4 Total 4 companies

6.3 High Content Screening/Analysis Cell Imaging Systems

6.3.1 to 6.3.5 Total 5 companies

6.4 Cell-Based Screening Assays/Reagents

6.4.1 to 6.4.5 Total 5 companies

6.5 Cell Screening Assays/Reagents

6.5.1 to 6.5.3 Total 3 companies

6.6 Contract Research and Development Services

6.6.1 to 6.6.3 Total 3 companies

6.7 Cell Screening/Analysis Software

6.7.1 to 6.7.4 Total 4 companies




7 Conclusions: Findings & Opportunities

7.1 Important Findings

7.1.1 Market Size and Growth

7.1.2 Alliances and IP

7.1.3 Bio-Pharma Product & Technology Users

7.1.4 Equipment

7.1.5 Services

7.2 The Cell-Based Screening & Analysis Business/ Tech Market Roadmap and Opportunities

7.2.1 Major CBSA Products & Services Segments by Growth Rate

7.2.2 Important Growth Areas Within Major Segments




8 Appendix

8.1 Company Contacts

8.2 Patent Data Tables




List of Tables

Table 1. Equipment for Cell Based Screening and Analysis

Table 2. Equipment Competitors by Large, Medium & Small Companies

Table 3. Consumables Competitors by Large, Medium & Small Companies

Table 4. Content Competitors by Large, Medium & Small Companies

Table 5. Services Competitors by Large, Medium & Small Companies

Table 6. Other Competitors by Large, Medium & Small Companies

Table 7. Wide Field vs. Confocal HCS/ HCA Equipment

Table 8. Confocal HCS/ HCA Imaging Equipment Used By Bio-Pharmas

Table 9. Summary of Cell-based M&As & Alliances, 2004 through 2006

Table 10. Summary of Cell-based M&As by Top Acquirers

Table 11. M&As and Alliances, 2006

Table 12. M&As and Alliances, 2005

Table 13. M&As and Alliances for Cell-Based Screening and Analysis, 2004

Table 14. CBA Related IP by No. of New Patents Issued, 2005 & 2006

Table 15. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.

Drug Discovery & Development (BPDD)

Table 16. WW Market by Major Segments & Revenues

Table 17. WW Market by Major Segments & Shares, 2007 & 2011

Table 18. 'Equipment' Segments by Product Type

Table 19. 'Consumables' Segments by Type

Table 20. 'Content' Segments by Type

Table 21. 'Services' Segments by Type

Table 22. The 'Others' Segment

Table 23. CBSA Market by Major Worldwide Regions

Table 24. Market by Major Worldwide Region Share, 2007 & 2011

Table 25. Leading 'Equipment' Vendors by Est. Market Share Rank

Table 26. Leading 'Consumables' Vendors by Est. Market Share Rank

Table 27. Major CBSA Products & Services Segments by Growth Rate

Table 28. 'Services' Sub-segments by Growth Rate

Table 29. 'Consumables' Sub-segments by Growth Rate

Table 30. 'Equipment' Sub-segments by Growth Rate

Table 31. Company Contacts, Web Links and State/Country

Table 32. Patent Data by Technology Type, Company, Patent and Title




List of Illustrations

Figure 1. WW Cell Based Screening and Analysis by Products & Services

Figure 2. Traditional Drug Discovery and Development Paradigm

Figure 3. MDC FLIPR vs. Competing HTS Flash Luminescence Plate Imagers

Figure 4. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.

Drug Discovery & Development (BPDD)

Figure 5. WW Market by Major Segments & Revenues

Figure 6. WW Market by Major Segments & Shares, 2007 & 2011

Figure 7. 'Equipment' Segments by Type

Figure 8. 'Consumables' Segments by Type

Figure 9. 'Content' Segments by Type

Figure 10. 'Services' Segments by Type

Figure 11. The 'Others' Segment

Figure 12. CBSA Market by Major Worldwide Regions

Figure 13. Market by Major Worldwide Region Share, 2007 & 2011

Figure 14. A Typical High Content Screening Solution

Figure 15. Molecular Devices Cell Based Screening Systems

Figure 16. Cellomics Imaging System for High Content Screening and Analysis

Abstract

This report reviews, analyzes and sizes the cell based screening and analysis market. The study uncovers interesting information about key equipment, consumables, reagents, software and services that are marketed to biotech and pharmaceutical companies that are doing drug discovery research.

Large bio-pharma companies have commented at industry meetings that fifty percent of their high throughput compound screening projects in drug discovery involves screening cells. The companies are using cell-based assays for both primary and secondary screening and have taken a great interest in the areas of high content screening and high content analysis.

The report assesses the market and maps the competitors on the market landscape with more than 80 companies identified. The financial section sizes the market and discusses the five-year revenue projection. The market is segmented by major product areas as well as market sub segments. This market is also segmented by major world regions to see the growth or how the market share might change.

Major company alliances, M&As, patents that were issued during the last two years are reviewed and analyzed. Large data tables summarize the alliances, M&As and patents. The alliance table summarizes more than 210 deals. The patent table displays key details of over 340 patents.

This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. More than 42 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like.

This report includes 28 company profiles that provide the reader a snapshot of the companies’ focus or activities. The provided Internet links help readers access companies’ own web sites for further review.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008